1019890-32-4

Basic information

• Product Name: 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)-N,N-di(prop-2-ynyl)benzamide
• CAS NO: 1019890-32-4
• Molecular Weight: 449.549
• Mol File: 1019890-32-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)-N,N-di(prop-2-ynyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)-N,N-di(prop-2-ynyl)benzamide(1019890-32-4)
• EPA Substance Registry System: 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)-N,N-di(prop-2-ynyl)benzamide(1019890-32-4)

Safety Data

• Hazardous Substances Data: 1019890-32-4(Hazardous Substances Data)

Usage

General Description

The chemical 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)-N,N-di(prop-2-ynyl)benzamide is a complex organic compound with a benzamide core structure. It contains multiple functional groups including benzyloxy, prop-1-en-2-yl, and prop-2-ynyl. These groups impart unique chemical properties to the compound, making it potentially useful in various chemical and pharmaceutical applications. The compound's specific structure and functional groups suggest that it could potentially be utilized in processes related to organic synthesis, drug development, or material science. However, further research and testing would be needed to determine its specific uses and potential benefits.

Upstream product

• 912545-09-6 2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)benzoic acid 
• 6921-28-4 dipropargylamine 
• 1619266-91-9 2,4-bis(benzyloxy)-5-isopropenyl-N-propargylbenzamide 
• 106-96-7 propargyl bromide 
• 540527-11-5 methyl 4-acetoxy-2-hydroxybenzoate 
• 912545-08-5 2,4-bis-benzyloxy-5-isopropenyl-benzoic acid methyl ester 
• 912545-07-4 5-acetyl-2,4-bis(benzyloxy)benzoic acid methyl ester 
• 6883-54-1 5-acetyl-2,4-dihydroxy-benzoic acid methyl ester 
• 2150-47-2 methyl 2,4-dihydroxybenzoate 
• 100-39-0 benzyl bromide 

Downstream Products

• 1351815-46-7 [2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl][5-(2-hydroxyethyl)-1,3-dihydro-2H-isoindol-2-yl]methanone 
• 1351815-44-5 [2,4-is(benzyloxy)-5-isopropenylphenyl]-[5-(hydroxymethyl)-1,3-dihydroisoindol-2-yl]methanone 
• 1351815-48-9 [2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl][5-(3-hydroxypropyl)-1,3-dihydro-2H-isoindol-2-yl]methanone 
• 1351815-58-1 cyclopentyl N-[(2-{[2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)methyl]-L-leucinate 
• 1351814-52-2 cyclopentyl N-[(2-{[2,4-dihydroxy-5-(propan-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)methyl]-L-leucinate 
• 1351815-59-2 cyclopentyl N-[2-(2-{[2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)ethyl]-L-leucinate 
• 1351814-59-9 cyclopentyl N-[2-(2-{[2,4-dihydroxy-5-(propan-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)ethyl]-L-leucinate 
• 1619266-92-0 [2,4-bis(benzyloxy)-5-isopropenylphenyl]-[5-(methanesulfonyloxymethyl)-1,3-dihydroisoindol-2-yl]methanone 
• 1019890-18-6 2-(2,4-bis-benzyloxy-5-isopropenylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone 
• 1351815-49-0 3-(2-{[2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)propanal 
• 1351815-47-8 (2-{[2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)acetaldehyde 
• 1351815-45-6 2-(2,4-bis-benzyloxy-5-isopropenylbenzoyl)-2,3-dihydro-1H-isoindole-5-carbaldehyde 
• 1351814-62-4 cyclopentyl N-[3-(2-{[2,4-dihydroxy-5-(propan-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)propyl]-L-leucinate 
• 1351815-60-5 cyclopentyl N-[3-(2-{[2,4-bis(benzyloxy)-5-(prop-1-en-2-yl)phenyl]carbonyl}-2,3-dihydro-1H-isoindol-5-yl)propyl]-L-leucinate 

Relevant articles and documents

Alternate synthesis of HSP90 inhibitor AT13387

AT13387 is a novel HSP90 inhibitor, and it is currently used in clinical trials for the treatment of refractory gastrointestinal stromal tumors (GIST). In this article, two synthetic routes are described for synthesizing the title compound via [2 + 2 + 2]

HYDROBENZAMIDE DERIVATIVES AS INHIBITORS OF HSP90

The invention provides an acid addition salt of a compound of the formula (1) Also provided by the invention are processes for preparing the compound of formula (1) and alkyl analogues thereof, novel intermediates for use in the process and methods for preparing the intermediates. The invention also provides new medical uses of compounds of the formula (1) and its ethyl analogue.